Company: VRCA
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001193125-25-087838
Chunk: 50

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 50
---
 Committee approved a cash incentive program pursuant to which our executive officers have aggregate cash bonus opportunities as detailed below, which can be earned based on the 38

achievement of specified sales metrics and financial milestones during the year ending December 31, 2025. The cash bonus applicable to a specified milestone will be paid during the next regularly scheduled payroll following the achievement of such milestone, subject to the executive officer’s continued service to us on the date such milestone is achieved.

| Name                 |     | Maximum Aggregate       
 Payment under 2025 Cash 
 Incentive Program       |   |         |
|:---------------------|:----|:------------------------|:--|--------:|
| Jayson Rieger        |     |                         | $ | 175,000 |
| Christopher G. Hayes |     |                         | $ | 100,000 |
| John J. Kirby        |     |                         | $ | 100,000 |
| David Zawitz         |     |                         | $ | 100,000 |

Equity-Based Awards Our equity-based incentive awards granted to our named executive officers are designed to align the interests of our named executive officers with those of our stockholders. Vesting of equity awards is generally tied to each officer’s continuous service with us and serves as an additional retention measure. Our executives generally are awarded an initial new hire grant upon commencement of employment. Additional grants may occur periodically in order to specifically incentivize executives with respect to achieving certain corporate goals or to reward executives for exceptional performance. In connection with its annual compensation review, our Compensation Committee granted options to purchase shares of our common stock to certain of our named executive officers, as detailed below, on March 14, 2025:

| Name                 |     | Number Of Shares 
 Underlying       
 Option Grant     |     |         |     | Exercise Price 
 Per Share      |   |      |     | Vesting  
 Schedule |     |    |
|:---------------------|:----|:-----------------|:----|--------:|:----|:---------------|:--|-----:|:----|:---------|:----|---:|
| Jayson Rieger        |     |                  |     | 850,000 |     |                | $ | 0.89 |     |          |     | -1 |
| Christopher G. Hayes |     |                  |     | 250,000 |     |                | $ | 0.89 |     |          |     | -2 |